Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГБОУ ДПО Иркутская государственная медицинская академия последипломного образования Минздрава России
Список исп. литературыСкрыть список 1. Алехин А.Н., Трифонова Е.А., Лебедев Д.С., Михайлов Е.Н. Психологические проблемы в аритмологии (на модели фибрилляции предсердий). Вестн. аритмологии. 2011; 63: 45–54. 2. Bunch TJ, Crandall BG, Weiss JP et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22 (8): 839–44. 3. Cheng YF, Leu HB, Su CC et al. Association Between Panic Disorder and Risk of Atrial Fibrillation: a Nationwide Study. Psychosom Med 2013; 75 (1): 30–5. 4. Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit 2011; 33 (4): 433–8. 5. Dąbrowski R, Smolis-Bąk E, Kowalik I et al. Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiol Pol 2010; 68 (10): 1133–9. 6. Dorian P, Jung W, Newman D et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36 (4): 1303–9. 7. Eaker ED, Sullivan LM, Kelly-Hayes M et al. Anger and Hostility Predict the Development of Atrial Fibrillation in Men in the Framingham Offspring Study. Circulation 2004; 109: 1267–71. 8. Efremidis M, Letsas KP, Lioni L et al. Association of quality of life, anxiety, and depression with left atrial ablation outcomes. Pacing Clin Electrophysiol 2014; 37 (6): 703–11. 9. Fayssoil A, Issi J, Guerbaa M et al. Torsade de pointes induced by citalopram and amiodarone. Ann Cardiol Angeiol (Paris) 2011; 60 (3): 165–8. 10. Finch SJ, Van Zyl LT. Cardioversion of persistent atrial arrhythmia after treatment with venlafaxine in successful management of major depression and posttraumatic stress disorder. Psychosomatics 2006; 47 (6): 533–6. 11. Frasure-Smith N, Lesperance F, Habra M et al. Elevated Depression Symptoms Predict Long-Term Cardiovascular Mortality in Patients With Atrial Fibrillation and Heart Failure. Circulation 2009; 120 (2): 134–40. 12. Gehi AK, Sears S, Goli N et al. Psychopathology and symptoms of atrial fibrillation: implications for therapy. J Cardiovasc Electrophysiol 2012; 23 (5): 473–8. 13. Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive Impairment Associated With Atrial Fibrillation: a Meta-analysis. Ann Intern Med 2013; 158: 338–46. 14. Lakkireddy D. Role of yoga and stress reduction techniques in the management of AF. Boston Atrial Fibrillation Symposium 2012. Boston, MA. January 12, 2012. 15. Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007; 63 (5): 509–13. 16. Mattioli AV, Bonatti S, Zennaro M et al. Effect of coffee consumption, lifestyle and acute life stress in the development of acute lone atrial fibrillation. J Cardiovasc Med (Hagerstown) 2008; 9 (8): 794–8. 17. McCabe PJ. Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs 2010; 25 (1): 40–51. 18. Patel D, Mc Conkey ND, Sohaney R et al. A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol 2013; 2013: Article 159850. 19. Perret-Guillaume C, Briancon S, Wahl D et al. Quality of Life in elderly inpatients with atrial fibrillation as compared with controlled subjects. J Nutr Health Aging 2010; 14 (2): 161–6. 20. Sang CH, Chen K, Pang XF et al. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clin Cardiol 2013; 36 (1): 40–5. 21. Schauer DP, Moomaw CJ, Wess M et al. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med 2005; 20 (12): 1114–9. 22. Sears SF, Serber ER, Alvarez LG et al. Understanding atrial symptom reports: objective versus subjective predictors. Pacing Clin Electrophysiol 2005; 28 (8): 801–7. 23. Shirayama T, Sakamoto T, Sakatani T et al. Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation. Am J Cardiol 2006; 97 (12): 1749–51. 24. Thompson TS, Barksdale DJ, Sears SF et al. The effect of anxiety and depression on symptoms attributed to atrial fibrillation. Pacing Clin Electrophysiol 2014; 37 (4): 439–46. 25. Thrall G, Lane D, Carroll D et al. Quality of Life in Patients with Atrial Fibrillation: a Systematic Review. Am J Med 2006; 119 (5): 448.e1–e19. 26. Thrall G, Lip GYH, Carroll D et al. Depression, Anxiety, and Quality of Life in Patients With Atrial Fibrillation. Chest 2007; 132: 1259–24. 27. Wozakowska-Kaplon B, Opolski G, Kosior D et al. Cognitive disorders in elderly patients with permanent atrial fibrillation. Kardiol Pol 2009; 67 (5): 487–93. 28. Von Eisenhart Rothe AF, Goette A, Kirchhof P et al. Depression in paroxysmal and persistent atrial fibrillation patients: a cross–sectional comparison of patients enroled in two large clinical trials. Europace 2014; 16: 812–9. 29. Yavuzkir M, Atmaca M, Dagli N et al. P-Wave Dispersion in Panic Disorder. Psychosom Med 2007; 69: 344–7. 30. Yu S, Zhao Q, Wu P et al. Effect of anxiety and depression on the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation. J Cardiovasc Electrophysiol 2012; 23 (Suppl. 1): S17–23.